\n<\/p>\n
A peer-reviewed, pre-proof report<\/a> to be published in the American Journal of Obstetrics and Gynecology found that mRNA from COVID-19 vaccines can \u201cspread systematically\u201d to the placenta and umbilical cord.<\/p>\n The study sought to analyze the \u201cpotential biodistribution of the vaccine\u2019s mRNA to the placenta and or the fetus after maternal vaccination,\u201d given that pregnant women were excluded from the initial COVID-19 mRNA vaccine trials.<\/p>\n To \u201cassess the presence of COVID-19 vaccine mRNA in the placenta and cord blood,\u201d the researchers vaccinated two pregnant women shortly before delivering the infants, one through vaginal delivery and the other by a cesarean section.<\/p>\n \u201cPatient 1,\u201d the woman planning to have a cesarean section, received four COVID-19 inoculations. There was a \u201cnotably high signal\u201d of mRNA in the decidua tissue, an endometrium layer that protects the baby during pregnancy, the study found.<\/p>\n mRNA was discovered in the placenta of \u201cpatient 2,\u201d the woman having a vaginal delivery, but not in \u201cpatient 1.\u201d<\/p>\n The findings \u201csuggest that the vaccine mRNA is not localized to the injection site and can spread systemically to the placenta and umbilical cord blood,\u201d the researchers wrote.<\/p>\n The report noted that the mRNA\u2019s integrity was less fragmented in the placenta than in the cord blood. \u201cNotably, the vaccine mRNA was largely fragmented in the cord blood and, to a lesser extent, in the placenta. To our knowledge, these two cases demonstrate, for the first time, the ability of the COVID-19 103 vaccine mRNA to penetrate the fetal-placental barrier and reach the intrauterine environment.\u201d<\/p>\n